Izvoz končan — 
Nalaganje...

Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies

It has been nearly two decades since RNA-interference (RNAi) was first reported. While there are no approved clinical uses, several promising phase II and III clinical trials suggest the great promise of RNAi therapeutics. One challenge for RNAi therapies is the controlled localization and sustained...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Adv Healthc Mater
Main Authors: Wang, Leo L., Burdick, Jason A.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226889/
https://ncbi.nlm.nih.gov/pubmed/27976524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201601041
Oznake: Označite
Brez oznak, prvi označite!